drugset / Trial / NCT01181921
The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to assess the modulating effect of galantamine on circadian rhythm in patients with moderate Alzheimer's disease.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Galantamine | Small molecule | 16 mg | Oral |
| Subject | Galantamine | Small molecule | 24 mg | Oral |